Calculus Capital Limited is a London-based private equity and venture capital firm that focuses on investing in established small and medium-sized enterprises within the United Kingdom. Founded in 1999, the firm specializes in funding expansions, management buy-outs, and growth capital for companies with positive EBITDA and sales of less than £50 million. Calculus Capital prioritizes sectors such as media, energy, digital marketing, pharmaceuticals, and technology, among others, while deliberately avoiding investments in start-ups and overseas businesses. The firm typically invests between £2 million and £5 million, aiming to take a Board seat in its portfolio companies. With a strong emphasis on tax-efficient investment strategies, Calculus Capital has garnered recognition for its performance and maintains an impressive track record. The firm usually holds its investments for four to five years, continually adapting its approach to align with market opportunities and regulatory changes.
Booked It is an online bookings management software company focused on transforming the leisure, hospitality, and entertainment sectors. Its platform offers customizable technology and innovative marketing solutions that seamlessly integrate with various applications and services. By leveraging data, Booked It enables businesses to implement highly targeted marketing campaigns aimed at enhancing customer experiences, driving foot traffic, and boosting revenue. The company's approach not only streamlines booking processes but also provides valuable insights that support effective decision-making within the industry.
Notify Technology
Venture Round in 2025
Notify Technology Ltd. operates an online platform focused on employee risk reporting and incident management. Founded in 2017 and based in Wallsend, United Kingdom, the company provides services that allow users to quickly record incidents, accidents, and near misses through a mobile app and web portal. Its customizable interface supports the management of both recurring and one-off events. The software enables organizations to track outcomes, actions, and trends through real-time dashboard reporting, ultimately enhancing workplace safety and health.
Invizius
Venture Round in 2024
Invizius is a biotech company focused on enhancing extracorporeal treatments for patients, particularly in the areas of dialysis, cardiopulmonary bypass, and ECMO. The company has developed H-Guard, an advanced hemocompatible coating designed to mitigate foreign body reactions in the bloodstream. This innovative coating acts as an anti-inflammatory treatment that lines the inside of dialysis filters, allowing the process to occur without triggering the body's immune response. By suppressing unwanted innate immune reactions, Invizius aims to reduce the risk of cardiovascular disease among patients undergoing long-term dialysis. The company's efforts are positioned to revolutionize the way dialysis and other extracorporeal treatments are administered, improving patient outcomes and overall treatment efficacy.
Optalitix
Venture Round in 2024
Optalitix is a cloud software provider that offers a platform designed for insurers and banks to host various models, including spreadsheets and AI applications. Their flagship product, Optalitix Models, enables clients to convert Excel spreadsheets into scalable systems without the need for coding. The platform leverages both internal and external data to generate insights, facilitating improved decision-making processes. In addition to model hosting, Optalitix offers a hosted underwriting workbench called Optalitix Quote, which enhances underwriting performance. The company also provides tools that utilize these hosted models to optimize credit origination, embedded insurance, sales insights, and broker sales, ultimately helping clients to underwrite insurance more effectively, acquire and retain customers, and personalize policy offerings.
WorkL
Series A in 2024
WorkL provides all the resources you need in one location to find employment, advance your career, connect with others, and communicate.
Tagomics
Seed Round in 2024
Tagomics is a company focused on enhancing disease diagnosis through advanced multitopic profiling and epigenetic-based technologies. It specializes in the development of chemicals that facilitate the discovery of epigenetic biomarkers, providing a second layer of information to DNA beyond the traditional genetic code. This innovative approach enables the identification of biological markers that are sensitive to lifestyle, environmental factors, and disease states. By concentrating on early detection, particularly for colorectal and other common cancers, Tagomics aims to improve patient outcomes through more effective and cost-efficient diagnostic methods.
MIP Discovery
Series A in 2024
MIP Discovery is a technology leader specializing in the development of molecularly imprinted polymers (MIPs) and nanoMIPs, which are plastic antibodies designed to address the limitations of traditional MIP manufacturing methods. The company's innovations feature polymers and antibodies that incorporate a single binding site for specific targets, allowing them to be effectively fused to solid substrates, such as sensor surfaces. This capability provides hospitals with highly effective reagents suitable for a variety of applications, including point-of-care diagnostics and field-based testing, thereby enhancing the efficiency and accuracy of medical testing.
Laverock Therapeutics
Seed Round in 2023
Laverock Therapeutics is focused on advancing gene silencing technology to create innovative programmable cell therapies. Their platform enables the engineering of next-generation allogeneic cell therapies that can adapt to both internal and external environmental signals. This capability allows for the development of induced pluripotent stem cell (iPSC)-derived products that offer enhanced efficacy, safety, and accessibility, addressing many of the challenges faced by traditional therapeutic methods. Through its pioneering approach, Laverock Therapeutics aims to facilitate significant advancements in the fields of medicine and biotechnology.
Arctic Shores
Series B in 2023
Arctic Shores Limited is a provider of human resource management services, specializing in behavior-based assessments for employers. Founded in 2014 and headquartered in Manchester, United Kingdom, the company utilizes a combination of neuroscience, artificial intelligence, and game technology to deliver data-driven insights that enhance the recruitment process. Their game-based assessments measure various personality and cognitive traits, including resilience and emotional stability, to provide a more objective and less biased approach to hiring. Arctic Shores aims to improve diversity, reduce employee attrition, and increase applicant engagement by matching candidates to suitable job profiles based on key competencies linked to success in specific roles. To date, the company has assessed over 400,000 candidates and collaborated with more than 100 global clients, facilitating fair selection decisions and enhancing the overall recruitment experience.
Wazoku
Series B in 2022
Wazoku Limited is a London-based company that specializes in web-based idea management tools aimed at fostering innovation within organizations. Established in 2011, Wazoku offers various solutions, including Custom Spotlight, Business Spotlight, Government Spotlight, and Idea Spotlight, which enable businesses to capture, evaluate, and prioritize ideas from employees, partners, and customers. These tools are designed to support organizations of all sizes in their innovation efforts, helping them to build a sustainable culture of innovation. In addition to its software offerings, Wazoku provides training, workshops, and consulting services to enhance the idea management process. The company is committed to integrating innovation and sustainability into its core operations, believing that every organization can innovate effectively at scale.
Optalitix
Venture Round in 2022
Optalitix is a cloud software provider that offers a platform designed for insurers and banks to host various models, including spreadsheets and AI applications. Their flagship product, Optalitix Models, enables clients to convert Excel spreadsheets into scalable systems without the need for coding. The platform leverages both internal and external data to generate insights, facilitating improved decision-making processes. In addition to model hosting, Optalitix offers a hosted underwriting workbench called Optalitix Quote, which enhances underwriting performance. The company also provides tools that utilize these hosted models to optimize credit origination, embedded insurance, sales insights, and broker sales, ultimately helping clients to underwrite insurance more effectively, acquire and retain customers, and personalize policy offerings.
RotaGeek
Venture Round in 2022
RotaGeek Ltd. specializes in developing a cloud-based rostering system that simplifies workforce management for various organizations, including businesses, healthcare providers, and day centers. Founded in 2009 and based in London, the company utilizes advanced algorithms and machine learning technologies to analyze complex data, enabling users to create efficient, personalized schedules and manage annual leave while ensuring compliance with labor regulations. RotaGeek's platform helps organizations predict and meet staffing demands, ultimately saving time and resources. The company has a diverse clientele, including prominent names such as O2, Dune, and William Hill, and continues to expand its reach in both London and Melbourne, with a commitment to enhancing scheduling capabilities through intelligent technology that benefits both businesses and their employees.
Axol Bioscience
Venture Round in 2022
Axol Bioscience Ltd. is a biotechnology company based in Little Chesterford, United Kingdom, specializing in human cell culture systems for disease modeling and drug discovery. It offers a range of products including iPSC-derived cells such as cardiomyocytes, neural stem cells, and various primary cells like endothelial and liver cells. The company also supplies essential media and growth supplements needed for cell culture, alongside disease models for conditions such as Alzheimer's and Parkinson's diseases. In addition to its product offerings, Axol provides custom services including cell and tissue sourcing, iPSC reprogramming, differentiation, and genome editing. Its products and services are distributed globally, reaching markets in North America, Asia, and Europe. Established in 2012, Axol operates from the Chesterford Research Park, known for its focus on innovation in the life sciences sector.
Hinterview
Series A in 2021
Hinterview Limited is a London-based company that specializes in video engagement and interviewing solutions for the recruitment and talent acquisition sector. Established in 2015, Hinterview provides a comprehensive suite of video tools designed to enhance various stages of the recruitment process. The platform enables recruiters to conduct live video interviews, receive candidate video submissions, record conversations, and administer questionnaires, facilitating a streamlined hiring workflow. By eliminating unnecessary first-stage interviews and geographical barriers, Hinterview helps recruiters significantly improve candidate engagement while also enhancing client experiences. The technology aims to reduce the time to hire, improve forecasting, and ultimately drive business growth by allowing recruitment agencies to deliver a premium service. With a growing user base among recruiters and talent acquisition professionals globally, Hinterview is positioned as a valuable resource in the recruitment landscape.
Weedingtech
Venture Round in 2021
Weedingtech are the manufacturers of Foamstream, the award winning, herbicide-free system of controlling weeds, offering the most effective alternative to traditional chemical herbicides. Available for the first time on a commercial basis to the amenity and water industries, it kills weeds using a precise application of hot water and foam. Discover how your organisation could benefit from this exciting new technology today.
Invizius
Series A in 2021
Invizius is a biotech company focused on enhancing extracorporeal treatments for patients, particularly in the areas of dialysis, cardiopulmonary bypass, and ECMO. The company has developed H-Guard, an advanced hemocompatible coating designed to mitigate foreign body reactions in the bloodstream. This innovative coating acts as an anti-inflammatory treatment that lines the inside of dialysis filters, allowing the process to occur without triggering the body's immune response. By suppressing unwanted innate immune reactions, Invizius aims to reduce the risk of cardiovascular disease among patients undergoing long-term dialysis. The company's efforts are positioned to revolutionize the way dialysis and other extracorporeal treatments are administered, improving patient outcomes and overall treatment efficacy.
Axol Bioscience
Venture Round in 2021
Axol Bioscience Ltd. is a biotechnology company based in Little Chesterford, United Kingdom, specializing in human cell culture systems for disease modeling and drug discovery. It offers a range of products including iPSC-derived cells such as cardiomyocytes, neural stem cells, and various primary cells like endothelial and liver cells. The company also supplies essential media and growth supplements needed for cell culture, alongside disease models for conditions such as Alzheimer's and Parkinson's diseases. In addition to its product offerings, Axol provides custom services including cell and tissue sourcing, iPSC reprogramming, differentiation, and genome editing. Its products and services are distributed globally, reaching markets in North America, Asia, and Europe. Established in 2012, Axol operates from the Chesterford Research Park, known for its focus on innovation in the life sciences sector.
eConsult
Series A in 2021
eConsult Health is a digital health company that operates an online consultation platform designed to improve patient access to healthcare and enhance the efficiency of medical practices. The platform allows registered NHS patients to access medical advice at any time, enabling them to enter their symptoms and receive immediate self-help guidance. This service facilitates online consultations between patients and medical professionals, streamlining the process of seeking care for both routine and emergency situations. By leveraging technology, eConsult Health aims to make healthcare more accessible and efficient for patients and providers alike.
MIP Diagnostics
Venture Round in 2020
MIP Diagnostics Limited, established in 2015 as a spin-out from the University of Leicester, specializes in the development of molecularly imprinted polymers (MIPs) and nanoMIPs, often referred to as plastic antibodies. Founded by a team of experts led by Professor Sergey Piletsky, the company focuses on commercializing innovative forms of these polymers. Its proprietary technology includes a novel method for producing nanoMIPs, which are nanostructured polymer particles designed with a single binding site for specific targets. While MIPs are known for their robustness, nanoMIPs offer additional advantages, including solubility and the ability to be integrated with solid substrates like sensor surfaces. This unique combination of properties makes MIPs and nanoMIPs suitable for a variety of applications, particularly in point-of-care diagnostics and field-based testing. Based in Bedfordshire, United Kingdom, MIP Diagnostics aims to leverage its expertise to advance diagnostic solutions.
Wazoku
Venture Round in 2020
Wazoku Limited is a London-based company that specializes in web-based idea management tools aimed at fostering innovation within organizations. Established in 2011, Wazoku offers various solutions, including Custom Spotlight, Business Spotlight, Government Spotlight, and Idea Spotlight, which enable businesses to capture, evaluate, and prioritize ideas from employees, partners, and customers. These tools are designed to support organizations of all sizes in their innovation efforts, helping them to build a sustainable culture of innovation. In addition to its software offerings, Wazoku provides training, workshops, and consulting services to enhance the idea management process. The company is committed to integrating innovation and sustainability into its core operations, believing that every organization can innovate effectively at scale.
RotaGeek
Venture Round in 2020
RotaGeek Ltd. specializes in developing a cloud-based rostering system that simplifies workforce management for various organizations, including businesses, healthcare providers, and day centers. Founded in 2009 and based in London, the company utilizes advanced algorithms and machine learning technologies to analyze complex data, enabling users to create efficient, personalized schedules and manage annual leave while ensuring compliance with labor regulations. RotaGeek's platform helps organizations predict and meet staffing demands, ultimately saving time and resources. The company has a diverse clientele, including prominent names such as O2, Dune, and William Hill, and continues to expand its reach in both London and Melbourne, with a commitment to enhancing scheduling capabilities through intelligent technology that benefits both businesses and their employees.
RotaGeek
Venture Round in 2020
RotaGeek Ltd. specializes in developing a cloud-based rostering system that simplifies workforce management for various organizations, including businesses, healthcare providers, and day centers. Founded in 2009 and based in London, the company utilizes advanced algorithms and machine learning technologies to analyze complex data, enabling users to create efficient, personalized schedules and manage annual leave while ensuring compliance with labor regulations. RotaGeek's platform helps organizations predict and meet staffing demands, ultimately saving time and resources. The company has a diverse clientele, including prominent names such as O2, Dune, and William Hill, and continues to expand its reach in both London and Melbourne, with a commitment to enhancing scheduling capabilities through intelligent technology that benefits both businesses and their employees.
FISCAL Technologies
Venture Round in 2019
FISCAL Technologies is a provider of forensic solutions designed to empower purchase-to-pay teams in managing organizational spending effectively. The company offers NXG Forensics, a risk management technology that helps organizations reduce fraud and risks, protect working capital, ensure reputational assurance, improve processes, strengthen compliance, maintain master files, and support ERP migration. Founded in 2003 and based in Reading, United Kingdom, FISCAL Technologies serves various sectors, including education, healthcare, manufacturing, retail, and government. The company's solutions are implemented on a continuous basis to proactively safeguard supplier spend and enhance profitability, having protected hundreds of millions of payments and earned the trust of over 250 leading organizations globally.
Blu Wireless Technology
Venture Round in 2019
Blu Wireless Technology is a Silicon IP company specializing in the development of 60GHz baseband technology aimed at enhancing WiGig and 4G backhaul applications. The company focuses on creating high-bandwidth communication systems tailored for the telecom and semiconductor markets, enabling clients to efficiently establish 5G infrastructure. Blu Wireless offers its technology as a complete System IP solution, capable of delivering data rates exceeding multiple Gbps over distances greater than 300 meters. With expertise in mmWave silicon IP and a deep understanding of market demands, Blu Wireless provides partners and customers with reliable solutions that stand out in a competitive landscape while remaining cost-effective and timely.
Wazoku
Series A in 2019
Wazoku Limited is a London-based company that specializes in web-based idea management tools aimed at fostering innovation within organizations. Established in 2011, Wazoku offers various solutions, including Custom Spotlight, Business Spotlight, Government Spotlight, and Idea Spotlight, which enable businesses to capture, evaluate, and prioritize ideas from employees, partners, and customers. These tools are designed to support organizations of all sizes in their innovation efforts, helping them to build a sustainable culture of innovation. In addition to its software offerings, Wazoku provides training, workshops, and consulting services to enhance the idea management process. The company is committed to integrating innovation and sustainability into its core operations, believing that every organization can innovate effectively at scale.
Essentia Analytics
Series A in 2019
Essentia Analytics Ltd, founded in 2013 and based in London, specializes in developing a platform that aids professional investors in enhancing their investment decision-making skills. The company focuses on helping fund managers identify their strengths and weaknesses by analyzing historical trade data and behavioral patterns. By merging existing data on investment decisions with additional contextual information, Essentia provides actionable insights that enable portfolio managers to refine their strategies. The company employs a combination of behavioral data analytics, psychological research, and decision support technology to uncover biases in investment activities. Through its services, Essentia aims to foster skill development and investment discipline among active fund managers, ultimately leading to improved performance.
Arecor
Venture Round in 2018
Arecor Limited is a biopharmaceutical company based in Cambridge, United Kingdom, specializing in stabilization technology solutions for the pharmaceutical and biotech sectors. Founded in 2006, Arecor utilizes its innovative formulation technology platform to enhance the commercial value and utility of proteins across various applications, including vaccines and therapeutic proteins. The company develops products targeting infectious diseases, diabetes, oncology, immunology, and hormone replacement therapies. It focuses on reformulating existing therapies to improve their stability and efficacy, enabling self-administration for patients through pre-filled syringes and injection pens. Notably, Arecor works on high-concentration formulations of antibodies, such as Trastuzumab and Rituximab, to improve treatment for conditions like breast cancer and non-Hodgkin’s lymphoma. Additionally, Arecor creates stable liquid formulations for vaccines and biological therapies, addressing challenges in degradation and stability. Through partnerships with leading pharmaceutical companies, Arecor aims to deliver advanced reformulations that enhance treatment options for patients.
Oxford Biotherapeutics
Venture Round in 2018
Oxford BioTherapeutics Ltd is a biotechnology company specializing in the development of targeted antibody-drug conjugates for cancer treatment. Utilizing its proprietary OGAP platform, which is one of the largest human protein databases, the company identifies a range of validated and novel antigen targets from various cancer types. Its leading product, OBT076, is an antibody-drug conjugate aimed at treating high-risk HER2 negative breast cancer, as well as other solid tumors such as gastric, lung, bladder, and ovarian cancers. In addition to its cancer therapies, Oxford BioTherapeutics is also engaged in developing antibody-based treatments for acute myeloid leukemia. The company has formed strategic collaborations with prominent antibody firms to enhance its pipeline of novel therapeutics. Established in 2003 and based in Oxon, United Kingdom, with a presence in San Jose, California, Oxford BioTherapeutics aims to improve patient outcomes through innovative treatments and the integration of companion diagnostics into its development processes.
Cloud Trade
Venture Round in 2018
CloudTrade, founded in 2010 and based in Bristol, United Kingdom, offers a streamlined solution for organizations to send and receive electronic business documents without the need for manual data entry. The company specializes in e-invoicing, e-orders, and PDF e-invoicing, allowing documents to be transmitted directly into the processing applications of trading partners. CloudTrade's approach is designed to eliminate barriers that often hinder supplier adoption of electronic invoicing, such as the need for software downloads or changes to existing billing processes. By utilizing standard tools like email, CloudTrade enables suppliers to send e-invoices easily, transforming PDFs and other documents into structured e-invoice data without requiring complex integration. This non-intrusive methodology facilitates rapid adoption among suppliers, promoting a shift away from paper-based processes and enhancing efficiency in electronic trading.
Weedingtech
Venture Round in 2018
Weedingtech are the manufacturers of Foamstream, the award winning, herbicide-free system of controlling weeds, offering the most effective alternative to traditional chemical herbicides. Available for the first time on a commercial basis to the amenity and water industries, it kills weeds using a precise application of hot water and foam. Discover how your organisation could benefit from this exciting new technology today.
Open Energy Market
Venture Round in 2018
Open Energy Market is a technology-driven company that provides an online trading platform focused on energy buying and management for medium to large enterprises in the United Kingdom. Founded in 2012 and headquartered in Guildford, Surrey, the company aims to simplify the procurement process by automating the management of energy contracts. Its platform captures and stores data, displaying prices offered by various suppliers, which enables clients to enhance reporting, forecasting, and portfolio management. By offering greater control and insight into the energy market, Open Energy Market helps businesses develop effective and sustainable energy strategies in a rapidly evolving industry.
Mologic
Venture Round in 2018
Mologic Ltd. is a UK-based company specializing in the development of diagnostic products primarily for the research market. Founded in 2003 by a father-son team, the company is committed to enhancing patient care and advancing research in various fields, including clinical research, diagnostic development, and wound care. Mologic offers a range of diagnostic tools, such as lateral flow kits for measuring Alpha-1 antitrypsin and desmosine in urine, as well as fMLP assay kits for detecting fMLP in human urine. In addition to its product offerings, the company provides services in assay and reagent development, clinical evaluation studies, and the creation of high-performance antibodies for challenging targets. Mologic aims to make significant contributions to healthcare and education through its innovative research and development efforts.
Axol Bioscience
Venture Round in 2017
Axol Bioscience Ltd. is a biotechnology company based in Little Chesterford, United Kingdom, specializing in human cell culture systems for disease modeling and drug discovery. It offers a range of products including iPSC-derived cells such as cardiomyocytes, neural stem cells, and various primary cells like endothelial and liver cells. The company also supplies essential media and growth supplements needed for cell culture, alongside disease models for conditions such as Alzheimer's and Parkinson's diseases. In addition to its product offerings, Axol provides custom services including cell and tissue sourcing, iPSC reprogramming, differentiation, and genome editing. Its products and services are distributed globally, reaching markets in North America, Asia, and Europe. Established in 2012, Axol operates from the Chesterford Research Park, known for its focus on innovation in the life sciences sector.
Origin Broadband
Venture Round in 2017
Origin Broadband Ltd. is an Internet service provider and network operator based in Doncaster, United Kingdom. Founded in 2011, the company specializes in delivering broadband and phone packages to both residential and business customers. It operates one of the largest telecommunications networks in the country and is committed to providing high-quality connectivity solutions. With a focus on ensuring an excellent communications experience, Origin Broadband maintains multiple exchange buildings and data centers to support its extensive service offerings.
Cornerstone
Venture Round in 2017
Cornerstone is a regular delivery service of razor blades and shaving supplies for men. Its service include German-engineered razors and British-blended skincare products. Cornerstone was founded in January 2013 and is based in London, United Kingdom.
Synpromics
Venture Round in 2017
Synpromics Ltd. specializes in the development and commercialization of synthetic promoters that regulate gene expression. Founded in 2010 and located in Edinburgh, United Kingdom, the company focuses on enhancing the safety and efficacy of cell and gene therapies through its proprietary genomics and bioinformatics technologies. By utilizing a comprehensive bioinformatics database, Synpromics enables the design and selection of product-specific promoters, which supports biological researchers and developers in creating innovative solutions in the fields of AgBio and bioprocessing. As of 2019, Synpromics operates as a subsidiary of Asklepios BioPharmaceutical, Inc.
Blu Wireless Technology
Venture Round in 2017
Blu Wireless Technology is a Silicon IP company specializing in the development of 60GHz baseband technology aimed at enhancing WiGig and 4G backhaul applications. The company focuses on creating high-bandwidth communication systems tailored for the telecom and semiconductor markets, enabling clients to efficiently establish 5G infrastructure. Blu Wireless offers its technology as a complete System IP solution, capable of delivering data rates exceeding multiple Gbps over distances greater than 300 meters. With expertise in mmWave silicon IP and a deep understanding of market demands, Blu Wireless provides partners and customers with reliable solutions that stand out in a competitive landscape while remaining cost-effective and timely.
Park Street Shipping
Venture Round in 2017
Park Street Shipping Ltd. is a marine transportation company based in London, United Kingdom, specializing in the operation of second-hand dry bulk vessels. The company focuses on purchasing and managing these vessels to provide shipping services for dry bulk cargo. Catering primarily to clients in Europe, Park Street Shipping aims to deliver efficient and reliable transportation solutions within the maritime sector.
Origin Broadband
Venture Round in 2017
Origin Broadband Ltd. is an Internet service provider and network operator based in Doncaster, United Kingdom. Founded in 2011, the company specializes in delivering broadband and phone packages to both residential and business customers. It operates one of the largest telecommunications networks in the country and is committed to providing high-quality connectivity solutions. With a focus on ensuring an excellent communications experience, Origin Broadband maintains multiple exchange buildings and data centers to support its extensive service offerings.
Weedingtech
Venture Round in 2017
Weedingtech are the manufacturers of Foamstream, the award winning, herbicide-free system of controlling weeds, offering the most effective alternative to traditional chemical herbicides. Available for the first time on a commercial basis to the amenity and water industries, it kills weeds using a precise application of hot water and foam. Discover how your organisation could benefit from this exciting new technology today.
Jumptastic
Seed Round in 2016
Jumptastic’s highly successful first park opened in Gloucester in 2015, offering 90 interlinked trampolines over 30,000 square feet. The park attracted more than 140,000 visitors in its first 12 months.
C4x Discovery Holdings
Post in 2016
C4X Discovery is a UK-based drug discovery and development company that leverages proprietary technologies to enhance the drug development process. Its key platforms include Taxonomy3, which performs advanced multivariate analysis of genetic data; Conformetrix, which measures the 3D shapes of drug molecules using experimental data; and 4Sight, which visualizes molecular structures in four dimensions. The company’s product pipeline features a range of therapeutic candidates targeting substance abuse disorders, inflammatory diseases, hematological cancers, and neurodegenerative conditions. C4X Discovery collaborates with reputable academic institutions, such as the University of Bristol and the University of Oxford, as well as pharmaceutical partners like AstraZeneca and Evotec, to further its research and development initiatives. Founded in 2007 and originally named Schosween 24 plc, C4X Discovery aims to optimize medicine design and improve drug safety through its innovative approaches in molecular structure determination.
Scancell Holdings
Post in 2016
Scancell is focused on developing innovative therapeutic vaccines aimed at treating cancer and infectious diseases, leveraging its proprietary technology platforms, ImmunoBody and Moditope. The company is advancing its lead cancer vaccine, SCIB1, which targets melanoma and is currently in Phase 1/2 clinical trials. Preliminary data from these trials indicated that SCIB1 may elicit an immune response potentially linked to clinical benefits for patients with malignant melanoma. Scancell's ImmunoBody platform is designed to generate strong T cell responses that specifically target and eliminate tumor cells, while the Moditope technology addresses immune suppression caused by tumors, enabling activated T cells to effectively attack otherwise concealed cancer cells.
Epistem
Funding Round in 2016
Epistem is a contract research organization that specializes in pharmacogenomics and provides support for drug discovery and development. The company serves global pharmaceutical businesses, biodefense programs, and biotechnology firms by offering pre-clinical and clinical development services. Epistem focuses on several specialist areas, including oncology, mucositis, and inflammatory bowel disease. Utilizing advanced gene expression technology, the company also develops drug-induced biomarkers, enhancing the drug development process. With a skilled technical team dedicated to delivering customized protocols and personalized service, Epistem aims to meet the unique needs of its clients in the pharmaceutical and biotechnology sectors.
Duvas Technologies
Private Equity Round in 2016
Duvas Technologies Limited specializes in the development and manufacturing of advanced air quality monitoring systems utilizing Differential Ultra Violet Absorption Spectroscopy. The company offers both mobile and fixed sensors capable of detecting multiple pollutants, including unsaturated hydrocarbons, nitrogen oxides, sulfur oxides, ammonia, and ozone, at trace levels. These sensors are designed for a variety of applications, including traffic monitoring and environmental assessments, catering to sectors such as oil and gas, industrial gas detection, and security and emergency services. Established in 2008, Duvas Technologies is headquartered in Woking, United Kingdom, with an additional operational presence in Dubai, United Arab Emirates.
Arcis Biotechnology
Funding Round in 2016
Arcis Biotechnology Limited specializes in the development and commercialization of nucleic acid sample preparation solutions. The company offers a range of ready-to-use kits designed for the rapid extraction of nucleic acids from various biological samples, including whole blood, saliva, and cells from plants and animals. Their products, such as the Arcis Sample Prep Kit and the Arcis Blood Kit, enable users to obtain genetic material in less than three minutes without the need for laboratory equipment or extensive sample preparation. The technology facilitates the extraction of DNA and RNA from small sample volumes, with applications in point-of-care diagnostics, forensic analysis, and genomic research. Arcis Biotechnology provides its solutions through distributors in multiple countries, including the United Kingdom, India, and Belgium. Established in 2013 and based in Warrington, United Kingdom, the company was formerly known as Arcis Molecular Limited before rebranding in 2018.
Once Upon a Time Marketing
Venture Round in 2015
Once Upon a Time London Limited is a marketing agency based in London, United Kingdom, incorporated in 2012. The company specializes in integrated marketing services, focusing on various channels including advertising, branding, and social media. Its offerings encompass a comprehensive range of services such as media planning and buying, retail marketing, and shopper marketing. Additionally, Once Upon a Time provides unique products like collectible music box sets and sports management services. The agency caters to clients across multiple sectors, including entertainment, gaming, sports, music, and hospitality, positioning itself as a versatile player in the marketing landscape.
IPV
Venture Round in 2015
IPV Ltd specializes in providing timecode-enabled technology solutions for the broadcast and video production sectors, facilitating efficient access to content. The company offers a range of tools, including a process engine for automated media workflows, a metadata management solution called Metadata Central, and a proxy-based real-time media asset management system. Additionally, IPV provides Live Logger for multi-camera logging, a plugin for Adobe Premiere Pro, Teragator for metadata aggregation, XCode2 for file-based transcoding, and an archive management solution. These offerings support various applications such as archive and media asset management, content preparation, sports logging, news production, and reality television production. By enhancing collaborative content production, IPV aims to improve productivity and generate additional revenue for its clients, which include broadcasters and media organizations globally. Established in 2004 and based in Histon, United Kingdom, IPV was formerly known as Telemedia Systems Ltd.
Mologic
Venture Round in 2015
Mologic Ltd. is a UK-based company specializing in the development of diagnostic products primarily for the research market. Founded in 2003 by a father-son team, the company is committed to enhancing patient care and advancing research in various fields, including clinical research, diagnostic development, and wound care. Mologic offers a range of diagnostic tools, such as lateral flow kits for measuring Alpha-1 antitrypsin and desmosine in urine, as well as fMLP assay kits for detecting fMLP in human urine. In addition to its product offerings, the company provides services in assay and reagent development, clinical evaluation studies, and the creation of high-performance antibodies for challenging targets. Mologic aims to make significant contributions to healthcare and education through its innovative research and development efforts.
Synpromics
Venture Round in 2015
Synpromics Ltd. specializes in the development and commercialization of synthetic promoters that regulate gene expression. Founded in 2010 and located in Edinburgh, United Kingdom, the company focuses on enhancing the safety and efficacy of cell and gene therapies through its proprietary genomics and bioinformatics technologies. By utilizing a comprehensive bioinformatics database, Synpromics enables the design and selection of product-specific promoters, which supports biological researchers and developers in creating innovative solutions in the fields of AgBio and bioprocessing. As of 2019, Synpromics operates as a subsidiary of Asklepios BioPharmaceutical, Inc.
Money Dashboard
Series A in 2015
Money Dashboard is an online personal financial management service that enables users to consolidate and view their financial accounts in one secure location. Launched in 2010, it allows individuals to track their spending across current accounts, savings accounts, and credit cards from various UK banks. The platform provides insights into users' financial habits, helping them monitor daily expenses, assess whether they are living within their means, and identify potential savings. By analyzing past spending patterns, Money Dashboard offers budgeting tools and forecasts future outgoings, empowering users to make informed financial decisions. The service is free to use, requiring only an online account with a UK financial institution and internet access. Users benefit from streamlined financial management, which can lead to time and cost savings by directing them towards more economical financial products and services.
Collagen Solutions
Post in 2014
Collagen Solutions plc is a London-based company that specializes in sourcing, developing, manufacturing, and supplying medical-grade collagen components and biomaterials. Their products are utilized in various applications including regenerative medicine, medical devices, and in-vitro diagnostics across global markets such as Europe, North America, and Asia. The company offers a diverse range of collagen formulations, including soluble collagen, collagen powders, and gels, catering to fields such as orthopaedics, sports medicine, dental care, and cardiovascular surgeries. Additionally, Collagen Solutions provides contract manufacturing services, encompassing technology transfer and regulatory support for collagen-based products. Their expertise extends to creating personalized medical-grade bovine collagen for use as tissue scaffolds in reconstructive and wound care procedures. Established in 2013, Collagen Solutions serves a variety of pharmaceutical and medical device companies, fostering long-term commercial relationships through its comprehensive support and product offerings.
Avvio
Venture Round in 2014
Avvio is a prominent direct booking platform and digital agency focused on serving hotels and accommodation providers. Established in 2002, the company has consistently expanded its offerings by leveraging advanced technologies to enhance direct booking growth while minimizing reliance on online travel agencies. A key innovation came in October 2017 when Avvio introduced an artificial intelligence-driven booking engine named Allora, designed to optimize the user experience on hotel websites and improve conversion rates. Avvio's comprehensive suite of services includes responsive booking technology, content management systems, and third-party integrations, all aimed at refining online distribution and sales strategies. Headquartered in Limerick, with additional offices in Dublin, London, and New York, Avvio supports numerous hotels worldwide in increasing their direct bookings and enhancing their overall profitability.
Inspiresport
Venture Round in 2014
Inspiresport is a specialist in school sports and travel, dedicated to delivering unique sports development programs across various sports, including football, rugby, netball, cricket, and hockey. The company focuses on providing inspirational sports tours for young players of all abilities, facilitating opportunities for skill development in schools and colleges. By offering guidance and advice, Inspiresport aims to help young athletes enhance their abilities and pursue careers in sports.
WheelRight
Venture Round in 2014
WheelRight Ltd, based in Kidlington, United Kingdom, specializes in the design and manufacture of advanced tire monitoring equipment. Founded in 2004 by John Catling and Michael Taylor, the company provides innovative solutions for in-motion tire pressure monitoring, axle weighing, and tire temperature recording. Its products are tailored for various sectors, including commercial transport, logistics fleets, government agencies, and personal vehicles. By utilizing sensor plates and high-resolution imaging technology, WheelRight's systems accurately measure tire pressure, tread depth, tread damage, and axle weight as vehicles pass over them. This technology helps clients enhance road transport safety, reduce operating costs, and minimize energy consumption and environmental impact.
Arcis Biotechnology
Funding Round in 2014
Arcis Biotechnology Limited specializes in the development and commercialization of nucleic acid sample preparation solutions. The company offers a range of ready-to-use kits designed for the rapid extraction of nucleic acids from various biological samples, including whole blood, saliva, and cells from plants and animals. Their products, such as the Arcis Sample Prep Kit and the Arcis Blood Kit, enable users to obtain genetic material in less than three minutes without the need for laboratory equipment or extensive sample preparation. The technology facilitates the extraction of DNA and RNA from small sample volumes, with applications in point-of-care diagnostics, forensic analysis, and genomic research. Arcis Biotechnology provides its solutions through distributors in multiple countries, including the United Kingdom, India, and Belgium. Established in 2013 and based in Warrington, United Kingdom, the company was formerly known as Arcis Molecular Limited before rebranding in 2018.
Yourgene Health
Post in 2014
Yourgene Health is a biotechnology company specializing in molecular diagnostics and genomic medicine. The firm develops and commercializes innovative genetic products and services, focusing on next-generation DNA analysis technology. Notably, it offers the IONA test, an advanced non-invasive prenatal screening test designed to detect Trisomy 21, 18, and 13. Additionally, the company provides the Sage prenatal screen, which utilizes cutting-edge DNA technology to analyze placental DNA in maternal blood. Yourgene Health operates through two primary segments: Genomic Technologies and Genomic Services, with the majority of its revenue generated from the Genomic Technologies segment.
Chop’d
Funding Round in 2014
Chop'd Ltd. is a salad bar chain based in London, United Kingdom, with locations in London, Manchester, and Leeds. Established in 2002, the company specializes in serving a variety of fresh food options, including salads, soups, stews, warm salads, protein packs, wraps, breakfast items, coffee, and cold drinks. Chop'd emphasizes the use of locally sourced ingredients, allowing customers to enjoy real, natural food with flavor. In addition to its in-store offerings, the company provides delivery services for corporate events and meetings and sells products online, catering to a diverse clientele seeking healthy meal options.
AOMi
Venture Round in 2014
Active Operations Management International (AOMi) is a world leader in back office workforce optimisation solutions.Active Operations Management (AOM™) is an innovative, market-leading approach to back office workforce optimisation which is designed to enable front-line managers and their staff to achieve high quality service levels at optimum cost. Using AOM, organisations gain a structured and consistent operations management capability that delivers proven results and lasting operational excellence.Since its launch in 2005, AOMi’s cloud-based workforce optimisation software has been adopted in 37 countries and is now used by 40,000 users worldwide. It has been embraced by organisations that understand the value of back office workforce optimisation. This growth and global reach was recognised in 2011 when AOMi received a Queen’s Award for Enterprise.
Quai Administration Services
Private Equity Round in 2014
Quai Administration Services Limited offers an integrated administration platform tailored for various savings and investment providers. The company supports discretionary fund managers, employee benefit consultants, independent financial advisers, and wealth managers by providing a comprehensive range of solutions for the administration of both proprietary and third-party products. Its platform includes options for managing a variety of investment accounts, such as self-invested personal pensions, individual savings accounts, and general investment accounts. Additionally, Quai Administration Services facilitates portfolio management, relationship management, and branded online services. The company also provides consulting services, product creation, and design, alongside capabilities for auto-enrolment and direct-to-consumer engagement. Founded in 2011 and based in Peterborough, United Kingdom, Quai Administration Services aims to enhance operational efficiencies and customer engagement through its compliant financial administration software.
Money Dashboard
Seed Round in 2013
Money Dashboard is an online personal financial management service that enables users to consolidate and view their financial accounts in one secure location. Launched in 2010, it allows individuals to track their spending across current accounts, savings accounts, and credit cards from various UK banks. The platform provides insights into users' financial habits, helping them monitor daily expenses, assess whether they are living within their means, and identify potential savings. By analyzing past spending patterns, Money Dashboard offers budgeting tools and forecasts future outgoings, empowering users to make informed financial decisions. The service is free to use, requiring only an online account with a UK financial institution and internet access. Users benefit from streamlined financial management, which can lead to time and cost savings by directing them towards more economical financial products and services.
Benito's Hat
Venture Round in 2013
Benito's Hat is the mexican food chain.
Human Race
Venture Round in 2012
Human Race is a prominent sports event management company based in the UK, specializing in mass participation events. It boasts a diverse portfolio of over 55 events annually, which includes triathlons, cycling, running, open water swimming, duathlons, and off-road competitions. Additionally, the company organizes corporate and youth events, catering to a wide range of participants. Through its comprehensive event management services, Human Race aims to foster community engagement and promote an active lifestyle among individuals of all ages and skill levels.
Metropolitan Safe Deposits
Private Equity Round in 2012
Metropolitan Safe Deposits is a provider of safe deposit box services in the United Kingdom, emphasizing traditional values such as trust, honesty, reliability, and service. The company offers secure storage solutions for a variety of valuable items, including gold, silver, legal documents, and other precious possessions, catering to both corporate clients and individual customers.
Spot something off? Help us improve by flagging any incorrect or outdated information. Just email us at support@teaserclub.com. Your feedback is most welcome.